SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09/09 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
13/26/13	€0.0870	-0.57%	2,63,752
12/26/12	€0.0875	-0.57%	3,21,581
11/26/11	€0.0880	+2.80%	1,17,790
10/26/10	€0.0856	-1.04%	5,40,517
07/26/07	€0.0865	-2.48%	1,88,201

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Market Closed - Euronext Paris 09:25:00 13/08/2026 pm IST			5-day change	1st Jan Change
0.0870 ^EUR	-0.57%		-1.92%	-13.86%

28/07	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
27/07	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI

Market Cap	81.68L 94.24L 76.57L 69.82L 1.31Cr 90Cr 1.33Cr 9.02Cr 3.52Cr 45Cr 3.54Cr 3.46Cr 150.19Cr	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	79.03L 91.18L 74.09L 67.55L 1.27Cr 87Cr 1.29Cr 8.72Cr 3.41Cr 44Cr 3.42Cr 3.35Cr 145.31Cr	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.68%	Yield 2024 *	-	Yield 2025	-

28/07	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
27/07	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI
27/07	SpineGuard Secures a New Patent in the United States
09/07	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07/07	Zonebourse earnings calendar for company results: July 8, 2026
27/05	SpineGuard Secures Three Patent Applications in US	MT
26/05	SpineGuard granted three new patents in the United States
26/05	Spineguard Obtains Three New Patents for Full Protection in the United States of Its Innovative Solutions Integrating Dsg Technology	CI
29/04	SpineGuard Officially Launches Newly Cleared Curved and XS PediGuard Models, in Nanjing	CI
14/04	SpineGuard Transfers US Unit's Assets, Executes Distribution Deal with Omnia Medical	MT
14/04	SpineGuard and Omnia Medical Complete Us Asset Transfer and Enter Exclusive Distribution Agreement for Pediguard Devices	CI
14/04	Omnia Medical, LLC completed the acquisition of Spineguard, Inc. from SpineGuard SA.	CI
09/04	SpineGuard SA Auditor Raises 'Going Concern' Doubt	CI

27/07	SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion	BU
08/07	SpineGuard Announces its H1 2026 Revenue	BU
26/05	SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology	BU
28/04	SpineGuard : Official launch of three New PediGuard® Models during the Annual Scoliosis Meeting in China	PU
28/04	SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China	BU

SpineGuard Share Price

Stocks

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news : SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Course Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

27/07	SpineGuard obtient un nouveau brevet aux Etats-Unis
27/07	SpineGuard et Omnia Medical obtiennent un nouveau brevet américain pour leur application innovante de la technologie DSG à la fusion de l'articulation sacro-iliaque
23/07	SpineGuard : Bilan semestriel du contrat de liquidité contracté avec la société de bourse TSAF
08/07	SpineGuard en mesure de financer son activité jusqu'au deuxième trimestre 2027
08/07	SpineGuard annonce son chiffre d’affaires du premier semestre 2026

1 day	-0.57%
1 week	-1.92%
Current month	+4.57%
1 month	+4.82%
3 months	-11.94%
6 months	-34.49%
Current year	-13.86%

1 week	0.08	0.09
1 month	0.08	0.1
Current year	0.08	0.14
1 year	0.08	0.3
3 years	0.08	0.5
5 years	0.08	1.77
10 years	0.08	5.45

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	15/02/2020
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	01/01/2009
Thibault Chandanson CTO	Chief Tech/Sci/R&D Officer	-	01/09/2019

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	16/01/2009
Maurice Bourlion BRD	Director/Board Member	-	02/07/2009
Pierre Jérôme CHM	Chairman	-	01/03/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	-0.57%	-1.92%	-13.00%	-80.09%	94.24L
PENUMBRA, INC.	+0.05%	+0.58%	+26.95%	+32.05%	1.29TCr
GETINGE AB	+0.25%	+0.93%	+18.88%	+27.37%	682.95Cr
ASAHI INTECC CO., LTD.	-1.12%	+4.91%	+55.36%	+37.16%	651.28Cr
MINIMED GROUP, INC.	-3.29%	+8.69%	-	-	562.25Cr
APT MEDICAL INC.	+0.69%	+3.71%	-26.75%	+50.75%	455.11Cr
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	-0.41%	-0.41%	-24.77%	-18.69%	397.83Cr
NOVOCURE LIMITED	-1.19%	+10.77%	+49.57%	-44.37%	202.38Cr
NAKANISHI INC.	-1.79%	+1.08%	+60.00%	-6.29%	174.31Cr
IMPLANTICA AG	+1.52%	-9.00%	-26.17%	+126.64%	158.73Cr
Average	-0.60%	+2.64%	+13.34%	+13.84%	457.28Cr
Weighted average by Cap.	-0.55%	+3.06%	+19.43%	+27.37%

	2024	2025
Net sales	46.48L 53.62L 43.57L 39.73L 74.75L 51Cr 75.95L 5.13Cr 2Cr 26Cr 2.01Cr 1.97Cr 85Cr	37.57L 43.35L 35.22L 32.12L 60.43L 41Cr 61.4L 4.15Cr 1.62Cr 21Cr 1.63Cr 1.59Cr 69Cr
Net income	-30.82L -35.55L -28.89L -26.34L -49.57L -34Cr -50.36L -3.4Cr -1.33Cr -17Cr -1.33Cr -1.31Cr -57Cr	-20.68L -23.85L -19.38L -17.67L -33.25L -23Cr -33.78L -2.28Cr -89.09L -11Cr -89.55L -87.61L -38Cr
Net Debt	18.19L 20.98L 17.05L 15.55L 29.25L 20Cr 29.72L 2.01Cr 78.37L 10Cr 78.77L 77.07L 33Cr	-3L -3L -2L -2L -4L -2.92Cr -4L -29.29L -11.44L -1.46Cr -11.49L -11.24L -4.88Cr